MaxCyte, Inc. (AIM: MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX
404.00
+10.00 (2.54%)
Jan 21, 2025, 4:35 PM GMT+1
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
237.91K GBP
Profits / Employee
-186.45K GBP
Market Cap
427.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
MaxCyte News
- 9 days ago - MaxCyte estimates higher Q4 core revenue from last year - Seeking Alpha
- 9 days ago - MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - MaxCyte Announces Retirement of Board Member Art Mandell - GlobeNewsWire
- 6 weeks ago - MaxCyte cuts 15% of global workforce, boosts core revenue guidance - Seeking Alpha
- 6 weeks ago - MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance - GlobeNewsWire
- 2 months ago - MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics - GlobeNewsWire
- 2 months ago - MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ... - GuruFocus
- 2 months ago - Q3 2024 MaxCyte Inc Earnings Call Transcript - GuruFocus